my experience of R/S has never been good but in conjunction of up listing would be acceptable if supported by positive news concerning fda approval of customer drugs
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.